SPDR S&P Biotech ETF Sees Unusually Large Options Volume (NYSEARCA:XBI)

SPDR S&P Biotech ETF (NYSEARCA:XBI) was the recipient of some unusual options trading on Tuesday. Stock traders bought 51,835 put options on the company. This represents an increase of approximately 41% compared to the typical daily volume of 36,668 put options.

Institutional Investors Weigh In On SPDR S&P Biotech ETF

Several institutional investors have recently modified their holdings of XBI. Bank of America Corp DE grew its holdings in shares of SPDR S&P Biotech ETF by 13.3% during the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after buying an additional 1,700,851 shares in the last quarter. Avoro Capital Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at approximately $256,053,000. OMERS ADMINISTRATION Corp boosted its holdings in SPDR S&P Biotech ETF by 42,425.2% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after buying an additional 1,187,907 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its holdings in shares of SPDR S&P Biotech ETF by 61.4% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 691,000 shares of the exchange traded fund’s stock valued at $84,254,000 after purchasing an additional 263,000 shares in the last quarter. Finally, Hsbc Holdings PLC boosted its stake in shares of SPDR S&P Biotech ETF by 7.8% during the 4th quarter. Hsbc Holdings PLC now owns 638,529 shares of the exchange traded fund’s stock worth $78,049,000 after purchasing an additional 46,339 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 2.6%

XBI traded down $4.03 during trading on Tuesday, hitting $153.57. 6,286,593 shares of the company traded hands, compared to its average volume of 9,046,919. The stock’s fifty day moving average is $158.20 and its 200 day moving average is $142.02. The firm has a market cap of $10.03 billion, a P/E ratio of 11.47 and a beta of 0.84. SPDR S&P Biotech ETF has a one year low of $93.26 and a one year high of $169.89.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.